Ham­mered on a gene ther­a­py set­back, Di­men­sion cuts staff and cir­cles the wag­ons

Di­men­sion Ther­a­peu­tics is win­now­ing out 25% of its staff as it con­cen­trates on three gene ther­a­py pro­grams, in­clud­ing one part­nered with Bay­er that has the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER